- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 271/113 - 1,3,4-OxadiazolesHydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
Patent holdings for IPC class C07D 271/113
Total number of patents in this class: 291
10-year publication summary
|
26
|
26
|
30
|
22
|
18
|
18
|
18
|
30
|
18
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer Cropscience AG | 1885 |
27 |
| King Faisal University | 927 |
16 |
| Bayer AG | 3430 |
10 |
| BASF SE | 21150 |
9 |
| Syngenta Crop Protection AG | 6513 |
7 |
| Cytokinetics, Inc. | 256 |
7 |
| Abbvie Inc. | 1842 |
6 |
| Calico Life Sciences LLC | 104 |
6 |
| Bayer Intellectual Property GmbH | 2405 |
5 |
| Oryzon Genomics S.A. | 102 |
5 |
| The General Hospital Corporation | 4827 |
4 |
| Northwestern University | 3513 |
4 |
| Cedars-Sinai Medical Center | 1189 |
4 |
| Denali Therapeutics Inc. | 261 |
4 |
| Romark Laboratories L.C. | 46 |
4 |
| Taisho Pharmaceutical Co., Ltd. | 858 |
4 |
| Qingdao Kingagroot Chemical Compound Co., Ltd. | 203 |
4 |
| Glaxo Group Limited | 4364 |
3 |
| Novartis AG | 10327 |
3 |
| AstraZeneca AB | 2832 |
3 |
| Other owners | 156 |